Personalized Focus Target Aquavit's emphasis on personalized medicine and innovative health technologies to position tailored clinical solutions, partnerships, and co-development opportunities with pharmaceutical, device, and diagnostics players seeking patient-specific approaches.

Expansion Opportunities Leverage their existing product launches and IP portfolio (AQV-1122, AQUAGOLD, SKINWORKOUT InnerB System) to propose expansion into related dermatology, aesthetic medicine, and personalized therapy spaces, including strategic collaborations and licensing deals.

Executive Leadership Engage via the new Chief Operating Officer and senior leadership to align value propositions around scalable operations, commercial strategy, and global partnerships, presenting MD/PI level collaboration and joint go-to-market plans.

Technology Enablement Highlight their tech stack and cloud-enabled workflows as a gateway for patient data integration, telemedicine, and digital health solutions, offering analytics, regulatory-compliant platforms, and secure data exchange with healthcare systems.

Financial Readiness Acknowledge modest revenue and funding levels as a potential for early-stage partnerships, co-development funding, and milestone-driven deals, while positioning Aquavit for scale with strategic investments and channel partnerships.